March 6, 2026 · Form 4 insider transaction
Parschauer Karah Herdman sold 6,018 shares of Ultragenyx Pharmaceutical Inc. at $21.40 per share, a transaction worth $128.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.